16 results on '"Gantsova E"'
Search Results
2. Changes in the Expression of the gapdh Gene in the Organs of insrr Knockout Mice
- Author
-
Gantsova, E. A., Gavrilenkova, A. A., Serova, O. V., and Deyev, I. E.
- Published
- 2022
- Full Text
- View/download PDF
3. Analysis of the Development of insrr Knockout Mouse Preimplantation Embryos
- Author
-
Gantsova, E. A., Deyev, I. E., Petrenko, A. G., and Serova, O. V.
- Published
- 2022
- Full Text
- View/download PDF
4. Tissue-Specific Expression of Neurexin-1α Isoforms in Rat Organs
- Author
-
Serova, O. V., Gantsova, E. A., Deyev, I. E., and Petrenko, A. G.
- Published
- 2022
- Full Text
- View/download PDF
5. The Value of pH Sensors in Maintaining Homeostasis of the Nervous System
- Author
-
Serova, O. V., Gantsova, E. A., Deyev, I. E., and Petrenko, A. G.
- Published
- 2020
- Full Text
- View/download PDF
6. A Comparative Kidney Transcriptome Analysis of Bicarbonate-Loaded insrr-Null Mice
- Author
-
Gantsova, E. A., primary, Serova, O. V., additional, Eladari, D., additional, Bobrovskiy, D. M., additional, Petrenko, A. G., additional, Elchaninov, A. V., additional, and Deyev, I. E., additional
- Published
- 2023
- Full Text
- View/download PDF
7. Venoms of kraits Bungarus multicinctus and Bungarus fasciatus contain anticoagulant proteins
- Author
-
Utkin, Yu. N., Gantsova, E. A., Andreeva, T. V., Starkov, V. G., Ziganshin, R. H., Anh, Hoang Ngoc, Thao, Nguyen Thi Thanh, Khoa, Nguyen Cuu, and Tsetlin, V. I.
- Published
- 2015
- Full Text
- View/download PDF
8. Effect of myoinositol in the development of preimplantation mouse embryos
- Author
-
Gantsova, E. A., primary, Chestkov, I. V., additional, Martynov, A. V., additional, Bekkerova, L. A., additional, Shchepkina, Yu. V., additional, and Chestkov, V. V., additional
- Published
- 2016
- Full Text
- View/download PDF
9. M1 macrophages as promising agents for cell therapy of endometriosis.
- Author
-
Artemova D, Vishnyakova P, Elchaninov A, Gantsova E, Sukhikh G, and Fatkhudinov T
- Abstract
Endometriosis is a chronic estrogen-dependent disease characterized by the presence of endometrial glands and stroma outside their normal anatomical location. While laparoscopic removal of foci remains the gold standard therapy, it has limited efficacy and certain risks. However, cell therapy using pro-inflammatory M1 macrophages presents a promising and minimally invasive alternative for treating endometriosis. This approach showcases the potential for innovative and effective treatments for this condition. This study aims to explore the anti-endometriosis properties of M1 macrophages. A reproducible syngeneic mouse model of endometriosis was utilized, revealing that formed foci are primarily composed of macrophages with an anti-inflammatory M2 phenotype rather than M1 macrophages. To investigate further, chemically reprogrammed M1 macrophages were labeled with the membrane fluorescent tag PKH26 and administered to animals with endometriosis. Therapy resulted in a decrease in the number and size of foci, accompanied by a shift in the phenotypic composition of peritoneal macrophages. Specifically, the content of M2 macrophages decreased while that of M1 macrophages increased, resembling the composition of healthy animals. Our study conclusively demonstrates the anti-endometriosis properties of M1 macrophages, providing a strong foundation for future research in the cell therapy of endometriosis., Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (© 2024 The Authors.)
- Published
- 2024
- Full Text
- View/download PDF
10. Changes in the Expression of Genes Regulating the Response to Hypoxia, Inflammation, Cell Cycle, Apoptosis, and Epithelial Barrier Functioning during Colitis-Associated Colorectal Cancer Depend on Individual Hypoxia Tolerance.
- Author
-
Dzhalilova D, Silina M, Tsvetkov I, Kosyreva A, Zolotova N, Gantsova E, Kirillov V, Fokichev N, and Makarova O
- Subjects
- Animals, Mice, Colorectal Neoplasms genetics, Colorectal Neoplasms metabolism, Colorectal Neoplasms pathology, Colorectal Neoplasms etiology, Gene Expression Regulation, Neoplastic, Hypoxia metabolism, Hypoxia genetics, Hypoxia complications, Colitis genetics, Colitis metabolism, Colitis complications, Colitis chemically induced, Colitis pathology, Male, Apoptosis genetics, Colitis-Associated Neoplasms pathology, Colitis-Associated Neoplasms genetics, Colitis-Associated Neoplasms metabolism, Colitis-Associated Neoplasms etiology, Inflammation genetics, Inflammation metabolism, Inflammation pathology, Cell Cycle genetics
- Abstract
One of the factors contributing to colorectal cancer (CRC) development is inflammation, which is mostly hypoxia-associated. This study aimed to characterize the morphological and molecular biological features of colon tumors in mice that were tolerant and susceptible to hypoxia based on colitis-associated CRC (CAC). Hypoxia tolerance was assessed through a gasping time evaluation in a decompression chamber. One month later, the animals were experimentally modeled for colitis-associated CRC by intraperitoneal azoxymethane administration and three dextran sulfate sodium consumption cycles. The incidence of tumor development in the distal colon in the susceptible to hypoxia mice was two times higher and all tumors (100%) were represented by adenocarcinomas, while in the tolerant mice, only 14% were adenocarcinomas and 86% were glandular intraepithelial neoplasia. The tumor area assessed on serially stepped sections was statistically significantly higher in the susceptible animals. The number of macrophages, CD3-CD19+, CD3+CD4+, and NK cells in tumors did not differ between animals; however, the number of CD3+CD8+ and vimentin+ cells was higher in the susceptible mice. Changes in the expression of genes regulating the response to hypoxia, inflammation, cell cycle, apoptosis, and epithelial barrier functioning in tumors and the peritumoral area depended on the initial mouse's hypoxia tolerance, which should be taken into account for new CAC diagnostics and treatment approaches development.
- Published
- 2024
- Full Text
- View/download PDF
11. A single-center experience of the upright proton therapy for skull-base chordomas and chondrosarcomas: Updated results.
- Author
-
Lemaeva A, Gulidov I, Smyk D, Agapova Y, Koryakin S, Eremina I, Gantsova E, Fatkhudinov T, Kaprin A, and Gordon K
- Abstract
Aim: To access efficacy and safety of the upright proton therapy for the skull-base chordomas and chondrosarcomas., Materials and Methods: The study encompasses single-center experience of proton therapy in chordomas (CA) and chondrosarcomas (CSA) of skull-base localization. We evaluate overall survival, local control and toxicity. Tumor response was assessed in accordance with RANO criteria. Treatment-related toxicity was evaluated with the help of CTCAE v 5.0 scale., Results: Proton therapy in the upright position was utilized for 51pts (patients) with CA-CSA (40 pts with chordoma and 11pts with chondrosarcoma) at the A. Tsyb Medical Radiological Research Center in 2016-2023. Median tumor volume constituted 30 cm
3 (IQR (interquartile range) 15-41 cm3 ). Median total dose was 70 GyRBE . Median number of fractions was 35. Overall survival (OS) at 1-, 2- and 3-year rates reached 98.0 %, 88.6 % and 82.7 %, respectively. Median follow-up time was 36 months. The 1-, 2- and 3-year local control (LC) rates constituted, respectively, 98 %, 78.6 % and 66.3 %. Prior surgery showed statistically significant association with better prognosis (p = 0.023). Brainstem-to-tumor dose coverage compromise became the major pattern of LC failure (p = 0.03). The late radiation toxicity reactions included temporal lobe necrosis grade 2 in 2 pts, xerostomia grade 1 in 1pt, radiation cataract grade 2 in 1pt and persistent headache grade 2 in 4 pts. Severe late toxicity reactions were observed in 2 cases (4 %): 1 myelitis grade 3 and brainstem damage grade 5 in 1pt., Conclusion: Local control was achieved in the majority of patients receiving the scanning-beam upright proton therapy for skull-base CA-CSA. The LC rates after a surgery-radiotherapy combination treatment were higher compared with irradiation alone. Pattern of failure is mostly brainstem-tumor dose compromise. The high OS and LC rates were accompanied by low toxicity incidence. Even in complex case of the skull base CA-CSA upright proton therapy shows promising clinical outcomes., Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (© 2024 The Authors.)- Published
- 2024
- Full Text
- View/download PDF
12. Mechanisms and physiological relevance of acid-base exchange in functional units of the kidney.
- Author
-
Gantsova E, Serova O, Vishnyakova P, Deyev I, Elchaninov A, and Fatkhudinov T
- Subjects
- Humans, Hydrogen-Ion Concentration, Animals, Bicarbonates metabolism, Acid-Base Equilibrium physiology, Kidney metabolism, Kidney physiology, Homeostasis physiology
- Abstract
This review discusses the importance of homeostasis with a particular emphasis on the acid-base (AB) balance, a crucial aspect of pH regulation in living systems. Two primary organ systems correct deviations from the standard pH balance: the respiratory system via gas exchange and the kidneys via proton/bicarbonate secretion and reabsorption. Focusing on kidney functions, we describe the complexity of renal architecture and its challenges for experimental research. We address specific roles of different nephron segments (the proximal convoluted tubule, the loop of Henle and the distal convoluted tubule) in pH homeostasis, while explaining the physiological significance of ion exchange processes maintained by the kidneys, particularly the role of bicarbonate ions (HCO
3 - ) as an essential buffer system of the body. The review will be of interest to researchers in the fields of physiology, biochemistry and molecular biology, which builds a strong foundation and critically evaluates existing studies. Our review helps identify the gaps of knowledge by thoroughly understanding the existing literature related to kidney acid-base homeostasis., Competing Interests: The authors declare that they have no competing interests., (© 2024 Gantsova et al.)- Published
- 2024
- Full Text
- View/download PDF
13. MicroRNA miR-27a as a possible regulator of anti-inflammatory macrophage phenotype in preeclamptic placenta.
- Author
-
Vishnyakova P, Gantsova E, Kiseleva V, Lazarev D, Knyazev E, Poltavets A, Iskusnykh M, Muminova K, Potapova A, Khodzhaeva Z, Elchaninov A, Fatkhudinov T, and Sukhikh G
- Subjects
- Female, Humans, Pregnancy, Anti-Inflammatory Agents, Macrophages metabolism, Phenotype, Receptor, Transforming Growth Factor-beta Type II genetics, Receptor, Transforming Growth Factor-beta Type II metabolism, Transforming Growth Factor beta genetics, Eosine Yellowish-(YS) analogs & derivatives, MicroRNAs genetics, MicroRNAs metabolism, Phosphatidylethanolamines, Placenta metabolism
- Abstract
Introduction: The role of the TGFβ signaling pathway, an important cascade responsible for the anti-inflammatory polarization of macrophages, in the development of both early- and late-onset preeclampsia (eoPE and loPE), remains poorly understood. In this study, we examined the components of the TGFβ signaling cascade and macrophage markers within placental tissue in normal pregnancy and in PE., Methods: Patients with eoPE, loPE, and normal pregnancy were enrolled in the study (n = 10 in each group). Following techniques were used for the investigation: immunohistochemistry analysis, western blotting, qRT-PCR, isolation of monocytes by magnetic sorting, transfection, microRNA sequencing, and bioinformatic analysis., Results: We observed a significant decrease in the anti-inflammatory macrophage marker CD206 in the loPE group, alongside with a significant down-regulation of CD206 protein production in both eoPE and loPE groups. The level of CD68-positive cells and relative levels of CD163 and MARCO production were comparable across the groups. However, we identified a significant decrease in the TGFβ receptor 2 production and its gene expression in the PE group. Further analysis revealed a link between TGFBR2 and MRC1 (CD206) genes through a single miRNA, hsa-miR-27a-3p. Transfecting CD14-derived macrophages with the hsa-miR-27a-3p mimic significantly changed TGFBR2 production, indicating the potential role of this miRNA in regulating the TGFβ signaling pathway. We also revealed the up-regulation of hsa-miR-27a-5p and hsa-miR-27a-3p in the trophoblast BeWo b30 cell line under the severe hypoxia condition and the fact that TGFBR2 3' UTR could serve as a potential target for these miRNAs., Discussion: Our findings uncover a novel potential therapeutic target for managing patients with PE, significantly contributing to a deeper comprehension of the underlying mechanisms involved in the development of this pathology., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2023 Elsevier Ltd. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
14. The spleen as a possible source of serine protease inhibitors and migrating monocytes required for liver regeneration after 70% resection in mice.
- Author
-
Elchaninov A, Vishnyakova P, Kuznetsova M, Gantsova E, Kiseleva V, Lokhonina A, Antonova M, Mamedov A, Soboleva A, Trofimov D, Fatkhudinov T, and Sukhikh G
- Abstract
Introduction: The role of the immune system in liver repair is fundamentally complex and most likely involves the spleen. The close connection between the two organs via the portal vein enables delivery of splenic cytokines and living cells to the liver. This study evaluates expression of inflammation-related genes and assesses the dynamics of monocyte-macrophage and lymphocyte populations of the spleen during the recovery from 70% hepatectomy in mice. Methods: The study used the established mouse model of 70% liver volume resection. The animals were sacrificed 24 h, 72 h or 7 days post-intervention and splenic tissues were collected for analysis: Clariom™ S transcriptomic assay, immunohistochemistry for proliferation marker Ki-67 and macrophage markers, and flow cytometry for lymphocyte and macrophage markers. Results: The loss and regeneration of 70% liver volume affected the cytological architecture and gene expression profiles of the spleen. The tests revealed significant reduction in cell counts for Ki-67+ cells and CD115+ macrophages on day 1, Ly6C + cells on days 1, 3 and 7, and CD3
+ CD8+ cytotoxic lymphocytes on day 7. The transcriptomic analysis revealed significant activation of protease inhibitor genes Serpina3n , Stfa2 and Stfa2l1 and decreased expression of cell cycle regulatory genes on day 1, mirrored by inverse dynamics observed on day 7. Discussion and conclusion: Splenic homeostasis is significantly affected by massive loss in liver volume. High levels of protease inhibitors indicated by increased expression of corresponding genes on day 1 may play an anti-inflammatory role upon reaching the regenerating liver via the portal vein. Leukocyte populations of the spleen react by a slow-down in proliferation. A transient decrease in the local CD115+ and Ly6C+ cell counts may indicate migration of splenic monocytes-macrophages to the liver., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Elchaninov, Vishnyakova, Kuznetsova, Gantsova, Kiseleva, Lokhonina, Antonova, Mamedov, Soboleva, Trofimov, Fatkhudinov and Sukhikh.)- Published
- 2023
- Full Text
- View/download PDF
15. The prospects of cell therapy for endometriosis.
- Author
-
Artemova D, Vishnyakova P, Gantsova E, Elchaninov A, Fatkhudinov T, and Sukhikh G
- Subjects
- Female, Humans, Estrogens therapeutic use, Killer Cells, Natural, Endometrium pathology, Cell- and Tissue-Based Therapy, Endometriosis therapy, Endometriosis drug therapy
- Abstract
Endometriosis is a chronic inflammatory estrogen-dependent disease characterized by the growth of endometrial-like tissue outside the physiological region. Despite the fact that this disease is common, laparoscopic surgery is currently the gold standard in the treatment of endometriosis. In this regard, it is necessary to develop new effective methods of minimally invasive therapy for endometriosis. One of the promising areas in the treatment of endometriosis is cell therapy. Cellular therapy is a vast branch of therapeutic methods with various agents. Potential cell therapies for endometriosis may be based on the principle of targeting aspects of the pathogenesis of the disease: suppression of estrogen receptor activity, angiogenesis, fibrosis, and a decrease in the content of stem cells in endometriosis foci. In addition, immune cells such as NK cells and macrophages may be promising agents for cell therapy of endometriosis. Standing apart in the methods of cell therapy is the replacement therapy of endometriosis. Thus, many studies in the field of the pathogenesis of endometriosis can shed light not only on the causes of the disease and may contribute to the development of new methods for personalized cell therapy of endometriosis., (© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
- Published
- 2023
- Full Text
- View/download PDF
16. Particle Therapy: Clinical Applications and Biological Effects.
- Author
-
Kiseleva V, Gordon K, Vishnyakova P, Gantsova E, Elchaninov A, and Fatkhudinov T
- Abstract
Particle therapy is a developing area of radiotherapy, mostly involving the use of protons, neutrons and carbon ions for cancer treatment. The reduction of side effects on healthy tissues in the peritumoral area is an important advantage of particle therapy. In this review, we analyze state-of-the-art particle therapy, as compared to conventional photon therapy, to identify clinical benefits and specify the mechanisms of action on tumor cells. Systematization of published data on particle therapy confirms its successful application in a wide range of cancers and reveals a variety of biological effects which manifest at the molecular level and produce the particle therapy-specific molecular signatures. Given the rapid progress in the field, the use of particle therapy holds great promise for the near future.
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.